de Bruijn I - Search Results

1

Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China.

Zhu FC, Zhou W, Pan H, Lu L, Gerez L, Nauta J, Giezeman K, de Bruijn I. Zhu FC, et al. Among authors: de bruijn i. Vaccine. 2008 Aug 18;26(35):4579-84. doi: 10.1016/j.vaccine.2008.05.082. Epub 2008 Jun 17. Vaccine. 2008. PMID: 18602729 Clinical Trial.

2

Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly.

de Bruijn IA, Remarque EJ, Beyer WE, le Cessie S, Masurel N, Ligthart GJ. de Bruijn IA, et al. Vaccine. 1997 Aug-Sep;15(12-13):1323-9. doi: 10.1016/s0264-410x(97)00019-4. Vaccine. 1997. PMID: 9302738 Free article.

3

The plea against annual influenza vaccination? 'The Hoskins' Paradox' revisited.

Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD. Beyer WE, et al. Among authors: de bruijn ia. Vaccine. 1998 Dec;16(20):1929-32. doi: 10.1016/s0264-410x(98)00123-6. Vaccine. 1998. PMID: 9796045

4

Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers.

de Bruijn IA, Nauta J, Gerez L, Palache AM. de Bruijn IA, et al. Virus Res. 2004 Jul;103(1-2):139-45. doi: 10.1016/j.virusres.2004.02.026. Virus Res. 2004. PMID: 15163502

5

Clinical experience with inactivated, virosomal influenza vaccine.

de Bruijn IA, Nauta J, Cramer WC, Gerez L, Palache AM. de Bruijn IA, et al. Vaccine. 2005 Jul 8;23 Suppl 1:S39-49. doi: 10.1016/j.vaccine.2005.04.020. Vaccine. 2005. PMID: 16005120 Clinical Trial.

6

The European CHMP criteria for influenza vaccine immunogenicity cannot be improved by the use of confidence intervals.

Nauta JJ, de Bruijn IA. Nauta JJ, et al. Vaccine. 2006 Nov 10;24(44-46):6643-4. doi: 10.1016/j.vaccine.2006.05.053. Epub 2006 Jun 5. Vaccine. 2006. PMID: 16797109

7

The virosomal influenza vaccine Invivac: immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad in elderly subjects.

de Bruijn IA, Nauta J, Gerez L, Palache AM. de Bruijn IA, et al. Vaccine. 2006 Nov 10;24(44-46):6629-31. doi: 10.1016/j.vaccine.2006.05.035. Epub 2006 Jun 5. Vaccine. 2006. PMID: 16901593 Clinical Trial.

8

Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly.

de Bruijn I, Meyer I, Gerez L, Nauta J, Giezeman K, Palache B. de Bruijn I, et al. Vaccine. 2007 Dec 21;26(1):119-27. doi: 10.1016/j.vaccine.2007.10.051. Epub 2007 Nov 12. Vaccine. 2007. PMID: 18063446 Clinical Trial.

9

Trivalent inactivated subunit influenza vaccine Influvac: 25-Year experience of safety and immunogenicity.

Giezeman KM, Nauta J, de Bruijn IA, Palache AM. Giezeman KM, et al. Among authors: de bruijn ia. Vaccine. 2009 Apr 21;27(18):2414-7. doi: 10.1016/j.vaccine.2009.02.008. Epub 2009 Feb 12. Vaccine. 2009. PMID: 19368782

10

Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres.

Pepin S, Dupuy M, Borja-Tabora CFC, Montellano M, Bravo L, Santos J, de Castro JA, Rivera-Medina DM, Cutland C, Ariza M, Diez-Domingo J, Gonzalez CD, Martinón-Torres F, Papadopoulou-Alataki E, Theodoriadou M, Kazek-Duret MP, Gurunathan S, De Bruijn I; GQM05 Study Group. Pepin S, et al. Among authors: de castro ja, de bruijn i. Vaccine. 2019 Mar 22;37(13):1876-1884. doi: 10.1016/j.vaccine.2018.11.074. Epub 2018 Dec 14. Vaccine. 2019. PMID: 30558818 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page